BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+155.4%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+155.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
16.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$133.58M+16.3%
2024$114.90M+449.3%
2023$20.92M+161.0%
2022$8.02M+171.1%
2021$-11.27M+98.8%
2020$-903.03M-1172.5%
2019$-70.96M-8.4%
2018$-65.49M-180.7%
2017$81.17M+140.4%
2016$-200.84M-